Health & Biotech
Top of mind: ASX companies tackling neurological disorders
Health & Biotech
Biocurious: When it comes to accurate measuring, the sky’s not the limit for Trajan
Health & Biotech
Cardiex launches industry-first at-home heart report
Health & Biotech
Health Check: Bargain hunters flock to 4D Medical’s discounted raising
Health & Biotech
Health Check: Opthea’s solvency in question after monumental phase III eye disease trial failure
Health & Biotech
Bioxyne to raise $3 million for European markets expansion
Health & Biotech
Scott Power: ‘Skip in our step’ as ASX health stocks shrug off losing streak
Health & Biotech
These ASX companies are stepping up to tackle traumatic brain injury head-on
Health & Biotech
Imricor raises a whopping $70 million for growth in pivotal year
Health & Biotech
How shifting to big pharma is paying off for Clever Culture Systems
Health & Biotech
Health Check: Join in the Coris as Nanosonics wins key FDA approval
Health & Biotech
Health Check: Emvision’s stroke detector takes to the skies
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.